Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
5 drugs across 2 manufacturers|1 Generic,4 Brand
Total Drugs
5
1G / 4B
Manufacturers
2
Avg $815.4654/unit
Avg 7d Change
-0.04%
Across 2 drugs with changes
7d Activity
1↑1↓3 flat
of 5 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
HARVONI 90-400 MG TABLET LEDIPASVIR and SOFOSBUVIR | $1098.9375 per EA | — |
SOVALDI 400 MG TABLET SOFOSBUVIR | $975.3000 per EA | — |
EPCLUSA 400 MG-100 MG TABLET Velpatasvir and Sofosbuvir | $866.0738 per EA | -0.13% |
VOSEVI 400-100-100 MG TABLET SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR | $858.6884 per EA | — |
SOFOSBUVIR-VELPATASVIR 400-100 Velpatasvir and Sofosbuvir | $278.3271 per EA | +0.06% |